Selective Expansion of Regulatory T-Cells during Lenalidomid Treatment of MDS with Isolated Deletion 5q
Martin Wermke(National Center for Tumor Diseases), Uwe Platzbecker(National Center for Tumor Diseases), Martin Bornhäuser(Technische Universität Dresden), Claudia Schuster(University Hospital Carl Gustav Carus), Claudia Schönefeldt(Innsbruck Medical University), Malte von Bonin(Städtisches Klinikum Dresden), Detlef Haase(Universitätsmedizin Göttingen), Sebastian Tuve, Gerhard Ehninger(University Hospital Carl Gustav Carus), Ulrich Germing(Heinrich Heine University Düsseldorf), Uta Oelschlaegel(University Hospital Carl Gustav Carus)
Cited by 0
Related Papers
Midostaurin plus Chemotherapy for Acute Myeloid Leukemia with a <i>FLT3</i> Mutation
|New England Journal of Medicine|2017|2.2k
Retinoic Acid and Arsenic Trioxide for Acute Promyelocytic Leukemia
|New England Journal of Medicine|2013|1.6k